Live Breaking News & Updates on Eurazeo Group

Stay updated with breaking news from Eurazeo group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EURAZEO : CONTINUES TO GROW ITS ASSET MANAGEMENT ACTIVITY AND INCREASES REALIZATIONS IN Q1 2024

EURAZEO : CONTINUES TO GROW ITS ASSET MANAGEMENT ACTIVITY AND INCREASES REALIZATIONS IN Q1 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

William Kadouch Chassaing , Christophe Bavi , Eurazeo Group , Eurazeo Planetary Boundaries Fund , Paying Assets Under Management , Under Management , Eurazeo Assets Under Management , Limited Partners , Wealth Management , Eurazeo Private Value Europe , Amolyt Pharma , Peters Surgical , Executive Board , Long Term Incentive Plans , Assets Under Management , Litman Gregory Wealth Management , Wedgewood Partner ,

Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio

CAMBRIDGE, Mass., October 04, 2023 Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that it has raised $35 million in Series B funding, led by Kurma Partners’ Growth Opportunities Fund, with participation from existing investors Seroba Life Sciences and Irish, U.S. and Canadian based family offices and Enterprise Ireland. The funding will enable Shorla to accelerate the growth of its oncology portfolio by advancing its pipeline, bringing therapies to ....

United Kingdom , Kurma Biofund , Sharon Cunningham , Daniel Parera , Orlaith Ryan , Us Department Of Health , Seroba Life Sciences , Kurma Partner Growth Opportunities Fund , Growth Opportunities Fund , Human Services , Eurazeo Group , Shorla Oncology , Nelarabine Injection , Specialty Pharma , European Healthcare , Life Science , Regulatory Overview , Systematic Review , European Venture Capital , Kurma Partners , Seriesb Funding , Urma Partners Growth Opportunities Fund , Sharon Cunningham , Kurma Partners , Enterprise Ireland , Pharmaceutical Company ,